Radiopharm Theranostics Limited
RADXNASDAQHealthcare● Active
$4.20
$-0.12(-2.78%)
Market Cap$5410440
P/E Ratio—
52W High$16.25
52W Low$3.62
外国私人发行人 · 提交 20-F / 6-K
Radiopharm Theranostics Limited（RADX）SEC 证券文件与年度报告
基于 SEC EDGAR 的监管申报（10-K、10-Q、8-K）、最新类型与完整申报历史；下方可跳转财务报表与盈利数据。
SEC EDGAR · data.sec.gov · CIK 0001949257 · RADX · NASDAQ · 截至 2026年6月8日
数据来源：SEC EDGAR (data.sec.gov) · CIK 0001949257 · 每小时更新 · 非投资建议
最新年度报告
20-F · 年度报告（外国发行人）财年
提交日期
2025-09-18
财年末
Sep 18, 2025
受理编号
0001213900-25-088699
主要文件
ea0246510-20f_radio.htm
数据来源：data.sec.gov · CIK 0001949257 · 受理号 0001213900-25-088699
最新关键披露
6-K季度报告
8-K即时报告
暂无最新申报
Form 4内幕交易
SEC 申报历史
隐藏 Form 4 / 144
提交日期
文件类型
说明
查看
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-03
2026-05-06
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-052990
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-06
2026-05-06
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-052518
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-06
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-01
2026-04-30
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-050607
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-30
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-23
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-20
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-08
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-07
2026-04-01
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-038788
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
2026-04-01
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-037929
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
2026-03-31
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-036753
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
2026-03-31
3
Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
0001213900-26-036748
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
显示 1–15，共 124 条Form 4 / 144 已隐藏
关于 SEC 申报文件与 10-K 年报
数据来源： SEC EDGAR (data.sec.gov) | 更新时间： Hourly | CIK： 0001949257 | 交易所： NASDAQ · Healthcare
Radiopharm Theranostics Limited（NASDAQ：RADX）自 2024 年 IPO 以来已向美国证券交易委员会（SEC）提交 124 份文件。CIK 为 0001949257，所有申报文件均可通过 SEC EDGAR 数据库免费查阅。
10-K 年度报告是 Radiopharm Theranostics Limited 最全面的监管披露文件。最新 RADX 10-K 于 2025-09-18 提交，财年截至 2025。历史年报可查阅 2022 至 2025 年度。
投资者可通过上方链接直接访问 Radiopharm Theranostics Limited SEC 申报文件，包括 10-K 年报、10-Q 季报、8-K 即时披露及代理声明（DEF 14A）。
数据来源：SEC EDGAR · data.sec.gov · Form 10-K · 10-Q · 8-K2026-06-08
相关公司 SEC 申报 — Healthcare
常见问题
RADX SEC 申报 · 8 个问题Radiopharm Theranostics Limited（RADX）的 SEC 申报文件可在本页及 SEC EDGAR（sec.gov）免费查阅。CIK 为 0001949257。
RADX SEC 申报Radiopharm Theranostics Limited SEC 文件RADX 10-K 查找